Inventor · disambiguated record
Jason B. Litten
Also filed as: LITTEN JASON B
0 granted patents·9 pending applications·0 citations·filing 2021–2022
Files withARTIVA BIOTHERAPEUTICS INC9
Top patents by PatentIndex Score
9 records- 0158US2024424099A1Treatment of cancer with nk cells and multispecific engagersARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0253US2025073264A1Chimeric antigen receptor comprising an anti-her2 antibody or antigen-binding fragment thereof and natural killer cells comprising the sameARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0352US2024180962A1Treatment of cancer with nk cells and a cd20 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0450US2024366663A1Chimeric antigen receptor comprising an anti-cd19 antibody or antigen-binding fragment thereof and natural killer cells comprising the sameARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0548US2024366664A1Treatment of cancer with nk cells and an egfr targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0648US2024197778A1Treatment of cancer with nk cells and a her2 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0747US2024115704A1Treatment of cancer with nk cells and a cd38-targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0847US2024000840A1Treatment of cancer with nk cells and a cd20 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0947US2024060046A1Expanded and stimulated natural killer cellsARTIVA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason B. Litten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →